Related Experiment Video
Updated: May 6, 2026
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
KidsBrainIT: Visualization of the Impact of Cerebral Perfusion Pressure Insult Intensity and Duration on Childhood
Bavo Kempen1, Bart Depreitere1,2, Ian Piper3,4
1Department of Neurosciences, KU Leuven, Leuven, Belgium.
Insights
This study visualizes pediatric cerebral perfusion pressure (CPP) dose-response for the first time, identifying a safe CPP range of 56-89 mm Hg for children with traumatic brain injury (TBI). Findings highlight the need for updated CPP targets in pediatric TBI management.
Area of Science:
- Pediatric neurocritical care
- Traumatic brain injury research
- Cerebrovascular physiology
Background:
- Cerebral perfusion pressure (CPP) management is critical for pediatric traumatic brain injury (TBI) outcomes.
- Previous research has not established a clear CPP dose-response relationship in pediatric TBI.
- This study utilizes the international multicenter KidsBrainIT dataset to address this knowledge gap.
Purpose of the Study:
- To generate the first visualization of pediatric CPP dose-response for post-TBI outcomes.
- To identify a "safe" CPP range for pediatric TBI patients.
- To explore the influence of cerebrovascular reactivity and intracranial pressure (ICP) on CPP-outcome relationships.
Main Methods:
- Analysis of minute-by-minute ICP, mean arterial blood pressure, and CPP data from 104 pediatric TBI patients.
- Categorization of CPP into intensity-duration episodes relative to various thresholds.
- Correlation of CPP episodes with 6-month Glasgow Outcome Score (GOS) and visualization in 3D color-coded plots.
Main Results:
- Pediatric CPP dose-response plots mirrored adult findings, with a transition curve separating good (blue) and poor (red) outcomes.
- A safe CPP range of 56-89 mm Hg was identified for pediatric TBI with active cerebrovascular reactivity and ICP < 20 mm Hg.
- Elevated ICP (> 20 mm Hg) was consistently associated with worse outcomes, regardless of CPP levels.
Conclusions:
- The study successfully visualized the pediatric CPP dose-response relationship for the first time.
- The identified critical lower CPP limit is higher than current pediatric TBI treatment recommendations.
- Evidence-based CPP clinical targets for pediatric TBI require urgent validation based on these findings.
Background:
Cerebral perfusion pressure (CPP) dose-response on post-traumatic brain injury (TBI) outcome in children remains unknown. This project aimed to produce the first pediatric post-TBI CPP dose-response visualization plot from the international multicenter KidsBrainIT data set.
Methods:
Fully anonymized prospectively collected routine minute-by-minute intracranial pressure (ICP), mean arterial blood pressure, and CPP time series data from 104 pediatric patients with TBI were categorized into CPP intensity duration episodes, albeit CPP above or below a range of thresholds. These episodes were then correlated with the 6-month modified Glasgow Outcome Score (GOS) and depicted in 3D color-coded CPP dose-response plots. Additionally, the effects of cerebrovascular reactivity patterns and ICP were examined.
Results:
Our pediatric CPP dose-response plots resembled the previously published adult CPP dose-response plots: on the CPP pressure time plots, an exponential "black" transition curve separated CPP episodes associated with poor ("red," GOS < 4) and good ("blue") outcome. Lower and higher ends of CPP intensity were only tolerated for shorter durations. A "safe" CPP zone (56-89 mm Hg) was identified for childhood TBI with active cerebrovascular reactivity pattern and ICP < 20 mm Hg. Passive cerebrovascular reactivity pattern reduced the area of safe CPP doses. ICP levels > 20 mm Hg were associated with worse outcome, irrespective of CPP dose.
Conclusions:
The pediatric CPP dose-response on poor outcome was visualized successfully for the first time. Because the "critical" lower CPP limit exceeds the current recommended minimum CPP target for pediatric TBI treatments, there is an urgent need to validate childhood CPP dose-response to provide evidence-based CPP clinical targets in the future.
Related Concept Videos
01:28Traumatic Brain Injury l: Introduction
01:29Increased Intracranial Pressure ll: Pathophysiology